Skip to main content
Erschienen in: International Urogynecology Journal 8/2010

01.08.2010 | Original Article

Symptomatic urinary tract infections after surgery for prolapse and/or incontinence

verfasst von: Gary Sutkin, Marianna Alperin, Leslie Meyn, Harold C. Wiesenfeld, Rennique Ellison, Halina M. Zyczynski

Erschienen in: International Urogynecology Journal | Ausgabe 8/2010

Einloggen, um Zugang zu erhalten

Abstract

Introduction and hypothesis

The purpose of our study was to estimate the frequency and risk factors for symptomatic urinary tract infection (UTI) after surgery for stress urinary incontinence (SUI) and/or pelvic organ prolapse (POP).

Methods

Case-control study of 389 consecutive women who underwent surgery for POP and/or SUI. Cases were defined as a symptomatic, culture-confirmed UTI within 6 weeks of surgery. Multivariable logistic regression was used to determine independent risk factors.

Results

Thirty five (9%) women developed a UTI. The risk of UTI was significantly increased by previous history of multiple UTIs (adjusted OR: 3.7, CI 1.4–10.1), increased distance between the urethra and the anus (adjusted OR: 1.4, CI 1.1–1.9), and prolonged duration of catheterization (adjusted odds ratio (OR) for ≥10 days: 4.2, 95% CI 1.5–11.6); 94.6% of catheterizing women were prescribed daily nitrofurantoin.

Conclusions

UTI is an important postoperative morbidity after urogynecologic surgery and is common in catheterizing women despite antibiotic prophylaxis.
Literatur
1.
Zurück zum Zitat Albo ME, Richter HE, Brubaker L, Norton P, Kraus S, Zimmern PE et al (2007) Burch colposuspension versus fascial sling to reduce urinary stress incontinence. N Engl J Med 356:2143–2155CrossRefPubMed Albo ME, Richter HE, Brubaker L, Norton P, Kraus S, Zimmern PE et al (2007) Burch colposuspension versus fascial sling to reduce urinary stress incontinence. N Engl J Med 356:2143–2155CrossRefPubMed
2.
Zurück zum Zitat FitzGerald MP, Richter HE, Bradley CS, Ye W, Visco AC, Cundiff GW, Zyczynski HM, Fine P, Weber AM (2008) Pelvic support, pelvic symptoms, and patient satisfaction after colpocleisis. Int Urogynecol J 19:1603–1609CrossRef FitzGerald MP, Richter HE, Bradley CS, Ye W, Visco AC, Cundiff GW, Zyczynski HM, Fine P, Weber AM (2008) Pelvic support, pelvic symptoms, and patient satisfaction after colpocleisis. Int Urogynecol J 19:1603–1609CrossRef
3.
Zurück zum Zitat Bump RC, Norton PA (1998) Epidemiology and natural history of pelvic floor dysfunction. Obstet Gynecol Clin North Am 25:723–746CrossRefPubMed Bump RC, Norton PA (1998) Epidemiology and natural history of pelvic floor dysfunction. Obstet Gynecol Clin North Am 25:723–746CrossRefPubMed
4.
Zurück zum Zitat Olsen AL, Smith VJ, Bergstrom JO, Colling JC, Clark AL (1997) Epidemiology of surgically managed pelvic organ prolapse and urinary incontinence. Obstet Gynecol 89:501–506CrossRefPubMed Olsen AL, Smith VJ, Bergstrom JO, Colling JC, Clark AL (1997) Epidemiology of surgically managed pelvic organ prolapse and urinary incontinence. Obstet Gynecol 89:501–506CrossRefPubMed
5.
Zurück zum Zitat Anger JT, Litwin MS, Wang Q, Pashos CL, Rodriguez LV (2007) Complications of sling surgery among female medicare beneficiaries. Obstet Gynecol 109:707–714PubMed Anger JT, Litwin MS, Wang Q, Pashos CL, Rodriguez LV (2007) Complications of sling surgery among female medicare beneficiaries. Obstet Gynecol 109:707–714PubMed
6.
Zurück zum Zitat Weber AM, Abrams P, Brubaker L, Cundiff G, Davis G, Dmochowsji RR et al (2001) The standardization of terminology for researchers in female pelvic floor disorders. Int Urogynecol J 12:178–186CrossRef Weber AM, Abrams P, Brubaker L, Cundiff G, Davis G, Dmochowsji RR et al (2001) The standardization of terminology for researchers in female pelvic floor disorders. Int Urogynecol J 12:178–186CrossRef
7.
Zurück zum Zitat Fihn SD (2003) Acute uncomplicated urinary tract infection in women. N Engl J Med 349:259–266CrossRefPubMed Fihn SD (2003) Acute uncomplicated urinary tract infection in women. N Engl J Med 349:259–266CrossRefPubMed
8.
Zurück zum Zitat Platt R, Polk F, Murdock B, Rosner B (1982) Mortality associated with nosocomial urinary-tract infection. N Engl J Med 307:637–642PubMedCrossRef Platt R, Polk F, Murdock B, Rosner B (1982) Mortality associated with nosocomial urinary-tract infection. N Engl J Med 307:637–642PubMedCrossRef
9.
Zurück zum Zitat Hooten TM, Stamm WE (1997) Diagnosis and treatment of uncomplicated urinary tract infection. Infect Dis Clin North Am 11:551–581CrossRef Hooten TM, Stamm WE (1997) Diagnosis and treatment of uncomplicated urinary tract infection. Infect Dis Clin North Am 11:551–581CrossRef
10.
Zurück zum Zitat Chai TC, Albo ME, Richter HE, Norton P, Dandreo KJ et al (2007) Analysis of adverse events from the stress incontinence surgical treatment efficacy trial (Sister). J Pelvic Medicine & Surgery 13:259, abstract Chai TC, Albo ME, Richter HE, Norton P, Dandreo KJ et al (2007) Analysis of adverse events from the stress incontinence surgical treatment efficacy trial (Sister). J Pelvic Medicine & Surgery 13:259, abstract
11.
Zurück zum Zitat Mutone N, Brizendine E, Hale D (2003) Factors that influence voiding function after the tension-free vaginal tape procedure for stress urinary incontinence. Am J Obstet Gynecol 188:1477–1483CrossRefPubMed Mutone N, Brizendine E, Hale D (2003) Factors that influence voiding function after the tension-free vaginal tape procedure for stress urinary incontinence. Am J Obstet Gynecol 188:1477–1483CrossRefPubMed
12.
Zurück zum Zitat Cox CE, Hinman F (1961) Experiments with induced bacteriuria, vesicle emptying and bacterial growth on the mechanism of bladder defenses to infection. J Urol 83:739 Cox CE, Hinman F (1961) Experiments with induced bacteriuria, vesicle emptying and bacterial growth on the mechanism of bladder defenses to infection. J Urol 83:739
13.
Zurück zum Zitat Foxman B, Brown P (2003) Epidemiology of urinary tract infections: transmission and risk factors, incidence, and costs. Infect Dis Clin N Am 17:227–241CrossRef Foxman B, Brown P (2003) Epidemiology of urinary tract infections: transmission and risk factors, incidence, and costs. Infect Dis Clin N Am 17:227–241CrossRef
14.
Zurück zum Zitat Barron KI, Savageau JA, Young SB, Labin LC, Morse AN (2006) Prediction of successful voiding immediately after outpatient mid-urethral sling. Int Urogynecol J 17(6):570–575, NovCrossRef Barron KI, Savageau JA, Young SB, Labin LC, Morse AN (2006) Prediction of successful voiding immediately after outpatient mid-urethral sling. Int Urogynecol J 17(6):570–575, NovCrossRef
15.
Zurück zum Zitat Benson JT, Lucente V, McClellan E (1996) Vaginal versus abdominal reconstructive surgery for the treatment of pelvic support defects: a prospective randomized study with long-term outcome evaluation. Am J Obstet Gynecol 175:1418–1421CrossRefPubMed Benson JT, Lucente V, McClellan E (1996) Vaginal versus abdominal reconstructive surgery for the treatment of pelvic support defects: a prospective randomized study with long-term outcome evaluation. Am J Obstet Gynecol 175:1418–1421CrossRefPubMed
16.
Zurück zum Zitat Mohler JL, Cowen DL, Flanigan RC (1987) Suppression and treatment of urinary tract infection in patients with an intermittently catheterized neurogenic bladder. J Urol 138:336–340PubMed Mohler JL, Cowen DL, Flanigan RC (1987) Suppression and treatment of urinary tract infection in patients with an intermittently catheterized neurogenic bladder. J Urol 138:336–340PubMed
17.
Zurück zum Zitat Dobbs SP, Jackson SR, Wilson AM, Maplethorpe RP, Hammond RH (1997) A prospective, randomized trial comparing continuous bladder drainage with catheterization at abdominal hysterectomy. Br J Urol 80:554–556PubMed Dobbs SP, Jackson SR, Wilson AM, Maplethorpe RP, Hammond RH (1997) A prospective, randomized trial comparing continuous bladder drainage with catheterization at abdominal hysterectomy. Br J Urol 80:554–556PubMed
18.
Zurück zum Zitat Trautner BW, Darouiche RO (2004) Catheter-associated infections. Arch Intern Med 164:842–850CrossRefPubMed Trautner BW, Darouiche RO (2004) Catheter-associated infections. Arch Intern Med 164:842–850CrossRefPubMed
19.
Zurück zum Zitat Saint S, Chenowith CE (2003) Biofilms and catheter-associated urinary tract infections. Infect Dis Clin N Am 17:411–432CrossRef Saint S, Chenowith CE (2003) Biofilms and catheter-associated urinary tract infections. Infect Dis Clin N Am 17:411–432CrossRef
20.
Zurück zum Zitat Wyndeale JJ (2002) Complications of intermittent catheterization: their prevention and treatment. Spinal Cord 40:536–541CrossRef Wyndeale JJ (2002) Complications of intermittent catheterization: their prevention and treatment. Spinal Cord 40:536–541CrossRef
21.
Zurück zum Zitat Galloway A, Green HT, Windsor JJ, Menon KK, Gardner BP, Krishnan KR (1986) Serial concentrations of C-reactive protein as an indicator of urinary tract infection in patients with spinal injury. J Clin Pathol 39:851–855CrossRefPubMed Galloway A, Green HT, Windsor JJ, Menon KK, Gardner BP, Krishnan KR (1986) Serial concentrations of C-reactive protein as an indicator of urinary tract infection in patients with spinal injury. J Clin Pathol 39:851–855CrossRefPubMed
22.
Zurück zum Zitat Rogers RG, Kammer-Doak D, Olsen A, Thompson PK, Walters MD, Lukcz ES, Qualls C (2004) A randomized, double-blind, placebo-controlled comparison of the effect of nitrofurantoin monohydrate macrocrystals on the development of urinary tract infections after surgery for pelvic organ prolapse and/or stress urinary incontinence with suprapubic catheterization. Am J Obstet Gynecol 191:182–187CrossRefPubMed Rogers RG, Kammer-Doak D, Olsen A, Thompson PK, Walters MD, Lukcz ES, Qualls C (2004) A randomized, double-blind, placebo-controlled comparison of the effect of nitrofurantoin monohydrate macrocrystals on the development of urinary tract infections after surgery for pelvic organ prolapse and/or stress urinary incontinence with suprapubic catheterization. Am J Obstet Gynecol 191:182–187CrossRefPubMed
23.
Zurück zum Zitat DeLancey JO, Hurd WW (1998) Size of the urogenital hiatus in the levator ani muscles in normal women and women with pelvic organ prolapse. Obstet Gynecol 91:364–368CrossRefPubMed DeLancey JO, Hurd WW (1998) Size of the urogenital hiatus in the levator ani muscles in normal women and women with pelvic organ prolapse. Obstet Gynecol 91:364–368CrossRefPubMed
24.
Zurück zum Zitat ACOG Practice Bulletin No. 91 (2008) Treatment of Urinary Tract Infections in Non-Pregnant Women. Obstet Gynecol 111:785–794 ACOG Practice Bulletin No. 91 (2008) Treatment of Urinary Tract Infections in Non-Pregnant Women. Obstet Gynecol 111:785–794
25.
Zurück zum Zitat Stamm WE, Raz R (1999) Factors contributing to susceptibility of postmenopausal women to recurrent urinary tract infection. Clin Infect Dis 28:723–725CrossRefPubMed Stamm WE, Raz R (1999) Factors contributing to susceptibility of postmenopausal women to recurrent urinary tract infection. Clin Infect Dis 28:723–725CrossRefPubMed
Metadaten
Titel
Symptomatic urinary tract infections after surgery for prolapse and/or incontinence
verfasst von
Gary Sutkin
Marianna Alperin
Leslie Meyn
Harold C. Wiesenfeld
Rennique Ellison
Halina M. Zyczynski
Publikationsdatum
01.08.2010
Verlag
Springer-Verlag
Erschienen in
International Urogynecology Journal / Ausgabe 8/2010
Print ISSN: 0937-3462
Elektronische ISSN: 1433-3023
DOI
https://doi.org/10.1007/s00192-010-1137-x

Weitere Artikel der Ausgabe 8/2010

International Urogynecology Journal 8/2010 Zur Ausgabe

Hirsutismus bei PCOS: Laser- und Lichttherapien helfen

26.04.2024 Hirsutismus Nachrichten

Laser- und Lichtbehandlungen können bei Frauen mit polyzystischem Ovarialsyndrom (PCOS) den übermäßigen Haarwuchs verringern und das Wohlbefinden verbessern – bei alleiniger Anwendung oder in Kombination mit Medikamenten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Weniger postpartale Depressionen nach Esketamin-Einmalgabe

Bislang gibt es kein Medikament zur Prävention von Wochenbettdepressionen. Das Injektionsanästhetikum Esketamin könnte womöglich diese Lücke füllen.

Bei RSV-Impfung vor 60. Lebensjahr über Off-Label-Gebrauch aufklären!

22.04.2024 DGIM 2024 Kongressbericht

Durch die Häufung nach der COVID-19-Pandemie sind Infektionen mit dem Respiratorischen Synzytial-Virus (RSV) in den Fokus gerückt. Fachgesellschaften empfehlen eine Impfung inzwischen nicht nur für Säuglinge und Kleinkinder.

Update Gynäkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.